title: Induction of remission of idiopathic anaphylaxis with rituximab.
authors.affiliation: Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: arturobor@med.puc.cl.
authors.forename: Arturo
authors.initials: A
authors.lastname: Borzutzky
authors.affiliation: Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Morales
authors.affiliation: Department of Rheumatology and Clinical Immunology at the School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
authors.forename: Verónica
authors.initials: V
authors.lastname: Mezzano
authors.affiliation: Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
authors.forename: Sofía
authors.initials: S
authors.lastname: Nussbaum
authors.affiliation: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
mesh_terms: D000293:Adolescent; D000485:Allergens / Q000009:adverse effects / Q000276:immunology; D000707:Anaphylaxis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D004351:Drug Resistance; D004837:Epinephrine / Q000008:administration & dosage; D005260:Female; D005502:Food / Q000009:adverse effects; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007167:Immunotherapy / Q000379:methods; D008212:Lymphocyte Depletion; D012008:Recurrence; D012074:Remission Induction; D065631:Rhinitis, Allergic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab
chemical_list: D000485:Allergens; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D007073:Immunoglobulin E; D000069283:Rituximab; D004837:Epinephrine